Evaluation of AP-002 in Patients With Solid Tumors

Recruiting

Phase 1

Phase 2

Evaluation of AP-002 in Patients With Solid Tumors

Sponsor:

Altum Pharmaceuticals INC

Code:

NCT04143789

Conditions

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AP-002

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-08. This information was provided to ClinicalTrials.gov by Altum Pharmaceuticals INC on 2019-10-31.